American Cannabis News

iAnthus Prepares to Capitalize on Florida Medical Cannabis Market Growth

iAnthus Highlights Cultivation Expansion and Dispensary Plans in Operational Update for GrowHealthy NEW YORK and TORONTO, Aug. 15, 2018 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF), which...
- August 15th, 2018 at 7:59 am

Surna Sales Grow 15% as Backlog Hits $8.9 Million

Surna Reports Q2 2018 Results BOULDER, Colorado, Aug. 14, 2018 /PRNewswire/ — Surna Inc. (OTCQB: SRNA) announced today operating and financial results for the three and six months ended...
- August 14th, 2018 at 8:29 am

C21 Investments to Buy Oregon Edibles Company for $6.8 Million

C21 Investments to acquire Grön Chocolate and Confections Cannabis firm expands into edibles to deepen product shelf VANCOUVER, Aug. 13, 2018 /PRNewswire/ – C21 Investments Inc. (CSE: CXXI) today announced it has entered...
- August 13th, 2018 at 8:14 am

GW Pharma Reveals Epidiolex Pricing

GW Pharmaceuticals (NASDAQ: GWPH) released financials for its fiscal 2018 Q3 after the close today and hosted a conference call for investors and analysts. Readers can access a full...
- August 7th, 2018 at 11:24 pm

iAnthus Capital to Present at 3 Conferences in August

iAnthus to Present at Canaccord’s 38th Annual Global Growth Conference, MJBizCon International and Benzinga Cannabis Capital Conference NEW YORK and TORONTO, Aug. 7, 2018 /CNW/ – iAnthus Capital Holdings,...
- August 7th, 2018 at 8:28 am

MPX Bioceutical Sales Rise 78% to $8 Million in Q4

MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018 Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation...
- August 2nd, 2018 at 3:29 pm

Global Cannabis Stocks Drop 10% in July

Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in July, declining 10.0% to 90.12 after posting a new 2018 low: The index, which had 53 qualifying members that...
- August 1st, 2018 at 12:34 pm

Aphria Q4 Sales Grow 81% to $12.1 Million

Aphria Records Revenue Increase of 17% in Quarter and 81% Year Over Year Adjusted gross margin increases to 78.7% of revenue as cash costs per gram remain below $1.00 Industry...
- August 1st, 2018 at 7:33 am

MPX Postpones Filing Date of 2018 Annual Statements

Company to reschedule conference call with shareholders upon finalization of financial results TORONTO, July 30, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC:...
- July 30th, 2018 at 4:56 pm